You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. Thousands of blood cancer patients could benefit from new drug combination
- 2. Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
- 3. Clarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
- 4. Diagnostic value of [18F]PSMA-1007 PET/CT based on PRIMARY score combined with mpMRI in clinically significant prostate cancer
- 5. Update in the clinical utilization of chemoprevention for breast cancer: a narrative review
- 6. Neutrophil extracellular traps and cannabinoids: potential in cancer metastasis
- 7. Research progress and molecular mechanism of oridonin in the treatment of malignant melanoma
- 8. Effects of gut microbiota in breast cancer
- 9. Abemaciclib treatment patterns and outcome in HR+/HER2- locally advanced or metastatic breast cancer: a real-world study from Kuwait and Lebanon
- 10. Eli Lilly looks beyond its blockbuster obesity drugs with another smart deal
Last updated at 14:26 GMT
Hot News Makers
Health/Pharma Companies
- 46746.13
- 41068.73
- 30642.79
- 18564.40
- 16664.44
- 9897.56
- 8841.08
- 8444.00
- 8070.32
- 8029.76
Drugs, Treatments, Trials
- 28055.39
- 16495.38
- 15356.45
- 14512.40
- 10201.96
- 8681.78
- 6468.69
- 5307.14
- 3544.38
- 3530.04
Last updated at 14:10 GMT
